Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD

NCT02123199 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol (Onbrez®) /QAB149

Sponsor

Novartis Pharmaceuticals